OPL102 Subgroup analyses from SENTINEL: a randomized controlled trial of natalizumab (Tysabri®) and interferon beta-1a (AVONEX®) in relapsing multiple sclerosis (MS)

• Book ID: 119466456
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 130 KB
• Volume: 238
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/s0022-510x(05)80278-3